Many clinical trials aren’t able to even move past the recruitment and enrollment stage. According to Deloitte, a “study on ...

Modern medicine is a marvel, with previously unimaginable cures and treatments now widely available. Think of advanced ...

From diving into the ever-evolving landscape of AI in drug development to opening up the conversation to discuss regulatory hurdles and how the industry will overcome them, the Summit has been ...

A real-world example of how Nimbus Therapeutics is navigating the complexity of managing over a decade of accumulated unstructured data by leveraging Egnyte to transform its data governance ...

Somerville, Mass-based Mass General Brigham has rolled out ambient documentation using generative AI to help draft clinical ...

Under this agreement, NetraMark's AI technology will initially be used for Phase 2 (neuroscience and oncology clinical trials) and select Phase 3 clinical trials conducted by Worldwide ...

The Toronto-based company, Altis Labs, claims its AI model is similarly superior at analyzing breast cancer and colorectal cancer scans, potentially offering drugmakers a better way to design their ...

AI-powered digital twins help ... s & Parkinson’s Drug Development Summit in Boston. The collaboration focused on remynd’s Phase 2a clinical trial of REM127, an investigational, first ...